3-AP 100 mg | 99.05%
TargetMol
3-AP (Triapine) is a novel inhibitor of the M2 subunit of ribonucleotide reductase (RR).
More Information Supplier Page3-AP
Search Results
YL-109 25 mg | 98.00%
TargetMol
YL-109, a novel anticancer agent, can inhibit breast Y cell growth and invasiveness in vitro and in vivo.
More Information Supplier PageYL-109
BRD4770 2 mg | 99.82%
TargetMol
BRD4770 is a histone methyltransferase G9a inhibitor and induces cell senescence.
More Information Supplier PageBRD4770
K02288 100 mg | 99.27%
TargetMol
K02288
K02288 2 mg | 99.27%
TargetMol
K02288
BAY 11-7082 200 mg | 97.91%
TargetMol
BAY 11-7082, a NF-κB inhibitor, inhibits TNFα-induced IκBα phosphorylation. BAY 11-7082 inhibits ubiquitin-specific protease USP7 and USP21.
More Information Supplier PageBAY 11-7082
BAY 11-7082 25 mg | 97.91%
TargetMol
BAY 11-7082, a NF-κB inhibitor, inhibits TNFα-induced IκBα phosphorylation. BAY 11-7082 inhibits ubiquitin-specific protease USP7 and USP21.
More Information Supplier PageBAY 11-7082
H-ASP-PHE-OH 100 mg | Purity Not Available
TargetMol
Rosuvastatin 200 mg | 99.80%
TargetMol
Rosuvastatin is an antilipemic agent that competitively inhibits hydroxymethyl-glutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Rosuvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.
More Information Supplier PageRosuvastatin
Rosuvastatin 25 mg | 99.80%
TargetMol
Rosuvastatin is an antilipemic agent that competitively inhibits hydroxymethyl-glutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Rosuvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.
More Information Supplier PageRosuvastatin